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Abstract
Helicobacter pylori (H. pylori) infects the gastric mucosa and persists for the life of the host. Bacterial persistence may be due
to the induction of regulatory T cells (Tregs) whichmay have protective effects against other diseases such as asthma. It has
been shown that H. pylori modulates the T cell response through dendritic cell reprogramming but the molecular pathways
involved are relatively unknown. The goal of this study was to identify critical elements of dendritic cell (DC) activation and
evaluate potential influence on immune activation. Microarray analysis was used to demonstrate limited gene expression
changes in H. pylori stimulated bone marrow derived DCs (BMDCs) compared to the BMDCs stimulated with E. coli. IRAK-M,
a negative regulator of TLR signaling, was upregulated and we selectedit for investigation of its role in modulating the DC
and T cell responses. IRAK-M2/2 and wild type BMDC were compared for their response to H. pylori. Cells lacking IRAK-M
produced significantly greater amounts of proinflammatory MIP-2 and reduced amounts of immunomodulatory IL-10 than
wild type BMDC. IRAK-M2/2 cells also demonstrated increased MHC II expression upon activation. However, IRAK-M2/2
BMDCs were comparable to wild type BMDCs in inducing T-helper 17 (TH17) and Treg responses as demonstrated in vitro
using BMDC CD4+ T cells co-culture assays,and in vivo though the adoptive transfer of CD4+ FoxP3-GFP T cells into H. pylori
infected IRAK-M2/2 mice. These results suggest that H. pylori infection leads to the upregulation of anti-inflammatory
molecules like IRAK-M and that IRAK-M has a direct impact on innate functions in DCs such as cytokine and costimulation
molecule upregulation but may not affect T cell skewing.
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Introduction
Helicobacter pylori (H. pylori) colonizes the gastric mucosa of over
half of the world’s population [1]. Infection lasts for life and is
associated with a variety of gastric diseases including peptic ulcer
disease, gastric adenocarcinoma, and MALT lymphoma [1–7].
Greater than 80% of infected people do not develop disease but
even asymptomatic individuals develop histologic gastritis [8,9].
The lack of disease in most individuals was originally believed to
be due in part to variations in bacterial virulence mechanisms
between H. pylori strains. It is becoming increasingly evident
however that limited disease is due in large part to host
immunoregulatory mechanisms, a response that also favors
bacterial persistence[10–17].
The development of histologic gastritis is T cell-dependent and
is predominantly driven by a mix of TH1 and TH17 responses [18–
23]. Despite the role of these T helper subsets in promoting
inflammation, it has been shown that regulatory T cells (Tregs)
accumulate in the gastric mucosa during chronic H. pylori infection
and contribute to persistent H. pylori colonization [10,13–15,17].
The loss of regulatory T cell function in murine models of
Helicobacter infection results in significantly increased inflammation
and reduced bacterial loads, demonstrating that these H. pylori-
mediated immunomodulatory effects may be beneficial to the host
and the bacteria[10,15,16]. The benefits to the host extend beyond
the stomach as H. pylori infection has been inversely correlated
with esophageal cancer in adults and wheezing in children. The
protective effects of H.pylori infection maybe dependent on
Tregs[24–27].
Down regulation of the host immune response is mediated by
regulatory T cells but the bacterial, environmental, and cellular
factors that promote the activation of regulatory T cells remain ill-
defined for H. pylori infection. Dendritic cells (DCs) are potent
antigen-presenting cells that are critical for the induction of
downstream adaptive immune responses [28,29] and they have
been demonstrated to play an important role in H. pylori infection.
DCs sense H. pylori primarily through Toll-like receptors (TLR) 2
and 4 in a MyD88 dependent manner [30,31]. H. pylori infection
however may skew the DC response to favor the generation of
Tregs cells via IL-18 dependent mechanisms [12,27]. This Treg
response, influenced by DCs, also protects against asthma in mice
[32].
A better understanding of how H. pylori affects DC function and
how DCs regulate downstream immune events may provide
additional insight into H. pylori pathogenesis and persistence but
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may also enhance our understanding of the host response to
mucosal bacteria in general. One of the mechanisms employed by
the host to limit microbial induced activation of APCs is the
expression of interleukin-1 receptor–associated kinase M (IRAK-
M), a negative regulator or TLR [33]. IRAK-M expression has
been demonstrated to limit immune activation to specific
pathogens, and to play a role in maintaining immune homeostasis
in the gut through its inducement by commensal bacteria [33–36].
We observed upregulation of IRAK-M in a transcriptome analysis
of H. pylori stimulated DCs, one of only ten genes to be induced.
The purpose of the present study therefore was to characterize the
role of IRAK-M in H. pylori-activated DCs and to determine
whether IRAK-M influences activation of the T cell response.We
now report that IRAK-M expression in DCs is dependent upon
TLR activation, and its expression is associated with limiting the
Figure 1. Global gene expression level changes in BMDCs stimulated with media alone, H. pylori or E. coli after 24 h. cRNA was
hybridized onto Illumina Mouse Ref8_v2.0 chips with probes for .24,000 genes (n = 3 for antigen lysate treated BMDCs, n = 2 for media treated
BMDCs). (A) The number of genes that were upregulated or downregulated in both treated groups compared to media alone. Data reflects probes
with an FDR ,0.1. (B) RT-PCR analysis confirmed that IRAK-M was significantly upregulated in BMDCS stimulated with either H. pylori or E. coli
compared to media alone at 4 h, 8 h and 24 h. (C) At 24 h, both Flt3L and GM-CSF derived BMDCs upregulated IRAK-M expression after stimulation
with either live SS1 bacteria (MOI 10), or SS1 and 26695 antigen lysate. **, P,0.01.
doi:10.1371/journal.pone.0066914.g001
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innate proinflammatory activity of the DC, as well as maturation
as measured by MHC II expression.
Methods
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocols were approved by the Institutional Animal Care and Use
Committee of the University of Maryland in Baltimore
(#0809004). All efforts were made to minimize pain and suffering.
Mice
Six- to thirteen-week-old C57BL/6, TLR22/2, and TLR42/2
mice were obtained fromJackson Laboratory (Bar Harbor, ME).
IRAK-M deficient mice were derived on a C57BL/6 background
as described previously [33] and were bred homozygously at the
University of Maryland School of Medicine (Baltimore, MD,
USA). C57BL/6 FoxP3-GFP mice and C57BL/6 OT-II Foxp3-
GFP mice were a generous gift from David Scott (Bethesda, MD,
USA) [37]. All animals were housed under pathogen-free
conditions in microisolater cages at the University of Maryland
Baltimore animal facilities. Mice were euthanized for tissue
collection by CO2 asphyxiation followed by thoracotomy.
Bacterial Strains and Infection
E. coli K12 was purchased from ATCC (#29425) (Manassas,
VA) and grown on LB plates supplemented with amphotericin B
(2.5 mg/ml). The mouse-adapted H. pylori Sydney Strain 1 (SS1)
[38]and strain 26695 (ATCC #700392) were grown on Columbia
agar (Difco, Detroit, MI) supplemented with7% horse blood and
antibiotics at 37uC. For inoculation of mice, bacteria were
transferred to 10 ml Brucella broth (Difco) supplemented with
10% fetal bovine serum (Invitrogen, Carlsbad, CA) and ampho-
tericin B (2.5 mg/ml). Liquid cultures were established in T25
flasks and maintained at 37uC with 10% CO2. Infections with H.
pylori SS1 were performed by delivering 16107 CFU in 0.5 ml
Brucella broth by oral gavage using a 20 G feeding needle
attached to a 1cc syringe. Antigen lysates were prepared as
previously described [39].
Generation of BMDCs and in Vitrostimulation Assays
Femurs and tibias were removed from 6–14 week old C57BL/6
WT, TLR22/2, TLR42/2, and IRAK-M2/2 mice at necropsy.
Bone marrow was flushed out with a syringe filled with RPMI
1640 and cells were cultured in RPMI medium supplemented with
either 100 gg/mL Flt3L (R&D Systems, Minneapolis, MN) or 7
gg/ml GM-CSF, and 10% heat inactivated FBS. Bone marrow
derived DC (BMDC) were recovered after 8–9 days and plated in
48 well plates at 16106 cells/well. Stimulation of BMDCs was
performed with 10 mg/mL of either H. pylori SS1 lysate, H. pylori
26695lysate or E. coli K12 lysate. For stimulation with live
bacteria, bacterial density was determined by optical density at
450 gm and used at a multiplicity of infection (MOI) of 10.
Supernatants were collected at 4, 8, and 24 hours after addition of
lysate for determination of TNFa, IL-10 and MIP-2 levels by
quantitative enzyme linked immunosorbent assay (ELISA) using
the relevant Duoset kits according to the manufacturer’s instruc-
tions (R&D Systems).
T Cell Co-culture Experiments
Coculture experiments were performed by plating 16105
BMDCs per well in 90 well U-bottom plates and stimulating with
10 mg/mL OVA peptide. CD4+ T cells were isolated from spleens
from 6–14 week old C57BL/6 OT-II Foxp3-GFP mice using the
CD4+ MagCellect Isolation Kit (R&D Systems) according to the
manufacturer’s instructions. T cells were added 56105 cells per
well to the BMDC in 96 well plates in the presence of either Treg
promoting conditions (20 ng/mL TGF-b (R&D Systems) & 25 U
of mIL-2 (E-bioscience, San Diego, CA), or TH17 promoting
conditions (2 ng/mL TGF-b (R&D Systems) & 20 ng/mL mIL-6
(Gemini Bio-products, Sacramento, CA). Alternatively, 16105
BMDCs were plated in 90 well U-bottom plates and stimulated
with media alone or 10 mg/mL H. pylori SS1 antigen lysate. CD4+
T cells were isolated from spleens from 6–14 week old C57BL/6
mice infected with H. pylori SS1 and 56105 T cells were added to
the wells in the absence of any additional stimulation.
Table 1. H. pylori associated gene expression changes.
Gene Name
Fold Change
(H. pylori vs. Media alone)
Antimicrobial peptides
Elastase 2, neutrophil (Ela2) 24.76
Cathelicidin antimicrobial peptide (CAMP) 23.27
Lipocalin 2 (Lcn2) 2.09
Anti-inflammatory molecules
Zinc finger CCCH type containing 12A (Zc3h12a) 1.46
Acyloxyacyl hydrolase (Aoah) 1.53
Interleukin-1 receptor-associated kinase 3 (Irak3/IRAK-M) 2.21
Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta (Nfkbiz/IkB-f) 2.71
Tribbles homolog 3 (Drosophila) (Trib3) 3.98
Vanin 3 (Vnn3) 4.06
Trafficking Molecules
Vesicle transport through interaction with t-SNAREs homolog 1A (yeast) (Vti1a) 1.70
doi:10.1371/journal.pone.0066914.t001
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Flow Cytometry Analysis
T-cells were stained with anti-CD4-APC and anti-IL17A-PE
(eBioscience). BMDCs were stained with anti-MHCII-Pacific Blue,
anti-PD-L1 PE, anti-CD40 PE-Cy5, anti-CD86 PE-Cy5
(eBioscience). All cells were analysed using a LSRII flow cytometer
(BD Biosciences, San Hose, CA). Data were analyzed by FlowJo7
software (Tree Star, Ashland, OR).
Adoptive Transfer Experiments
CD4+ T cells were isolated from the spleens of FoxP3-GFP
mice using the MagCellect Mouse CD4+ T cell isolation kit (R&D
Systems) and sorted for GFP negative cells using a BD FACSAria
flow cytometer. A total of 26106 CD4+, GFP2 cells were
transferred into WT and IRAK-M2/2 recipients by tail vein
injection. Animals were infected with SS1 on day 3 and animals
were harvested at 8 weeks for analysis. RNA was isolated from
gastric tissue using the RNeasy kit (Qiagen, Germantown, MD)
and converted to cDNA for qPCR analysis of GFP expression.
RNA Isolation, Microarray Processing and Microarray
Statistical Analysis
BMDCs were recovered following stimulation at the indicated
timepoints and RNA was isolated using the RNeasy kit (Qiagen).
cRNA was prepared from RNA using the Illumina TotalPrep
RNA amplification kit. cRNA samples were hybridized onto
Illumina MouseRef8_v2.0 bead array chips (San Diego, CA)
containing 25,967 probes (n = 3 for antigen lysate treated BMDCs,
n = 2 for media treated BMDCs). Analysis was performed using
the limma R package to compare gene expression profiles among
different stimulated groups compared to media-treated BMDCs.
Only probes with a false discovery rate (FDR) of ,0.1 were
included. Raw and normalized data sets were deposited into the
NCBI Gene Expression Omnibus database under accession
number GSE 44954.
Quantitative real-time PCR
Quantitative PCR analysis was performed by first converting
1 mg RNA to cDNA using the Quantitect reverse transcription kit
(Qiagen). cDNA was diluted 10-fold and PCR amplication was
performed with an Eppendorf Realplex Instrument (Eppendorf
AG, Hamburg, Germany) on 96 well plates with SYBR Green
supermix (Fermentas, Glen Burnie, MD) in either duplicate or
tripiclate. Each reaction mixture contained: 12.5 mL SYBR green
mix, 11.1 mL dH2O, 0.2 mL each forward and reverse primers at
0.8 mM, and 1 mL cDNA. Primer sequences were as follows:
IRAKM: TGAGCAACGGGACGCTTT (forward), GATTC-
GAACGTGCCAGGAA (reverse) [40]; GAPDH: CCAGG-
TTGTCTCCTGCGACTT (forward), CCTGTTGCTGTAG-
CCGTATTCA (reverse); GFP: CCTGAAGTTCATCTGCAC-
CACC (forward), CTGCTGGTAGTGGT- CGGCGAGC (re-
verse). Relative gene expression changes were calculated using the
DDCT method, and expression normalization was done using the
housekeeping gene glyceraldehyde 3-phosphate dehydrogenase
(GAPDH).
Statistical Analysis
Statistical analysis was performed using GraphPad Prism for
Macintosh 5.0 c (GraphPad Software, San Diego, CA). The
Mann-Whitney test was used for analysis of statistical significance
and a P value ,0.05 was considered significant.
Figure 2. IRAK-M2/2 BMDCs exhibited a more proinflammatory
phenotype after H. pylori stimulation compared to WT BMDCs.
Supernatant from H. pylori antigen-stimulated WT and IRAK-M2/2
BMDCs were collected at 4 h, 8 h and 24 h and used to determine (A)
TNFa, (B) MIP-2, and (C) IL-10 levels by ELISA. Data reflects three
independent experiments. Error bars indicate standard deviations.
*, P,0.05; **, P,0.01.
doi:10.1371/journal.pone.0066914.g002
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Figure 3. BMDCs stimulated for 24 h with H. pylori antigen were collected for flow cytometry analysis to determine (A) MHC-II
expression and (B) PD-L1 expression compared to cells in media alone and isotype controls. Graphical representation of mean 6 SD
from data collected from three individual experiments performed in duplicate is shown on the right. Graphical representation of surface expression
(C) CD86 and (D) CD40 determined by flow cytometry analysis *, P,0.05; **, P,0.01.
doi:10.1371/journal.pone.0066914.g003
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Results
H. pylori Stimulation of BMDCs Results in Gene
Expression Changes in a Limited Set of Genes after
24 hours
To identify the molecular pathways activated by H. pylori
stimulation in DCs, we performed microarray analysis on BMDCs
stimulated for 24 hours with either E. coli or H. pylori bacterial
lysate. As expected, E. coli-stimulated BMDCs (EC-BMDCs)
exhibited gene expression changes in many genes (Figure 1A).
More than half of 2162 impacted genes were downregulated.
Surprisingly, H. pylori-stimulated BMDCs (HP-BMDCs) showed
limited gene expression changes with only 10 genes significantly
affected in their expression (Table 1). Six of the 10 genes are
implicated in anti-inflammatory pathways. Since H. pylori has been
demonstrated to activate DCs primarily through TLR2 and TLR4
[30,31], we were particularly interested in the increased expression
of IRAK-M, a negative regulator of TLR signaling[33]. Using a
qPCR approach, we confirmed that IRAK-M was indeed
upregulated in BMDCs following activation with H. pylori lysate,
and that in contrast to EC-BMDCs, IRAK-M expression in HP-
BMDCs remained significantly high at 24 hour (P,0.01;
Figure 1B). IRAK-M was demonstrated to be significantly
upregulated in H. pylori-stimulated BMDC generated with either
Figure 4. (A)IRAK-M induction in BMDCs after H. pylori stimulation is dependent on TLR expression. RNA from WT, TLR22/2, TLR42/2 BMDCs was
collected at 4 h, 8 h and 24 h and converted to cDNA. qPCR was used to determine relative IRAK-M expression levels. The diagram represents mean
6 SD from data collected from two individual experiments performed in duplicate. (B) Supernatants collected from H. pylori antigen-stimulated WT,
TLR22/2 and TLR42/ BMDCs were collected at 4 h, 8 h and 24 h and used to determine (B) IL-10 and (C) MIP-2 levels by ELISA. *, P,0.05; **, P,0.01.
doi:10.1371/journal.pone.0066914.g004
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Flt3L or GM-CSF (P,0.01; Figure 1C) and this response was
consistent with using lysates from either the Hp SS1 or the
common laboratory strain 26695. Live Hp SS1 was also
demonstrated to induce significant levels of IRAK-M expression
although less effective than lysate antigen (P,0.01).
Lack of IRAK-M in BMDCs Results in a More Pro-
inflammatory Phenotype in HP-BMDCs
IRAK-M has been shown to play a role in DC activation in a
tumor vaccine and in a LPS endotoxin tolerance model of H. pylori
activation. [41,42] Therefore, we wanted to determine if IRAK-M
expression affects cytokine production in HP-BMDCs by com-
paring WT and IRAK-M2/2 BMDCs. IRAK-M2/2 cells have
previously been shown to have a more proinflammatory pheno-
type [33,41]. BMDCs deficient in IRAK-M responded to H. pylori
antigens by producing TNFa and MIP-2 as early as four hours
post activation and peaking at eight hours when levels of both
cytokines were significantly higher than for WT BMDCs (P,0.05;
Figure 2A and 2B; Supplemental Figure 1).TNFa levels remained
higher in IRAK-M2/2 cells at 24 hours post stimulation (P,0.01).
IL-12p70 was also measured but were undetectable (data not
shown).This is consistent with our previous observations using H.
felis activation of BMDC [43].Conversely, HP-BMDCs secreted
significantly less IL-10 compared to WT HP-BMDCs at all time
points although levels increased steadily over the 24-hour period
(Figure 2C).
Cell surface analysis of activated cells showed that IRAK-M2/2
HP-BMDCs expressed higher levels of MHC II
(P,0.01;Figure 3A), suggesting that IRAK-M normally limits
DC activation as measured by MHC II expression in response to
H. pylori stimulation. Conversely, expression of the down
regulatory co-receptor PD-L1 was significantly reduced in
activated IRAK-M2/2 BMDC compared to WT cells
(P,0.05; Figure 3B), indicating that IRAK-M normally limits
the potential of DC to activate Th cells upon activation with H.
pylori. Co-receptors CD86 and CD40 however remained compa-
rable between activated IRAK-M2/2 and WT BMDC
(Figures 3C and 3D). Together, these data suggest that in response
to H. pylori stimulation, IRAK-M expression contributes to a lack
of DC maturation and promotes a regulatory phenotype
exemplified by IL-10 production.
IRAK-M upregulation in HP-BMDCs is dependent on both
TLR2 and TLR4
TLR2 and TLR4 have been shown to play an important role in
H. pylori sensing by DCs [31]. We therefore sought to determine if
either TLR2 or TLR4 might be important in IRAK-M
upregulation by comparing HP-BMDCs from WT, TLR22/2
and TLR42/2mice. Whereas WT HP-BMDC displayed a 15-fold
increase in IRAK-M expression by eight hours that remained high
at 24 hours, Figure 4A illustrates that IRAK-M upregulation in
HP-BMDCs is dependent on both TLR2 and TLR4 expression,
and that abrogation of either TLR results in a reduction in IRAK-
M expression(P,0.05).Additional evidence for the importance of
both TLR2 and TLR4 in H. pylori lysate induced activation of DC
is demonstrated in Figure 4B and 4C where expression of IL-10
and MIP-2 respectively are shown to be significantly reduced
compared to BMDC from WT mice (P,0.01). Although
expression of both cytokines increased by 24 hours for TLR4
KO cells, these cytokines were largely absent in the cells from
TLR2 deficient mice.
IRAK-M expression in DCs does not affect TH17
differentiation in T cells
Since TH17 cells have been shown to contribute to the gastritis
seen in H. pylori infection as well as to protection against H. pylori in
experimental murine vaccine models [21,44–46], we sought to
determine whether the proinflammatory phenotype of IRAK-M2/
2 BMDCs might increase TH17 activation using a DC-T cell
coculture system. Studies using H. pylori stimulated BMDC cells to
stimulate splenic CD4+ cells from mice infected with H. pylori
showed no increase in either IFNc or IL-17 producing cells from
either WT or IRAK-M2/2 mice (Supplemental Figure 2). This is
consistent with the suppression that occurs in the H. pylori-specific
T cell response in infected hosts. T cells from transgenic mice with
a TCR specific for the OVA antigen were used to increase the
frequency of responsive cells. IRAK-M2/2 BMDCs were similar
to WT BMDCs in their ability to generate IL-17A+CD4+ T cells
(Figure 5A and 5B). There was no difference in the number of IL-
17A+ T cells following OVA exposure when H. pylori activated DC
from WT and IRAK-M2/2 were used as APC cells.
IRAK-M2/2 BMDCs are Comparable to WT BMDCs in
Generating Tregs
Since the balance of TH17/Tregs cells contributes to the extent
of the inflammatory response in H. pylori infection [12], we also
sought to determine if Treg generation is affected by the lack of
IRAK-M in BMDCs using the DC-T cell co-culture system
described above. The OVA TCR transgenic mice are also
transgenic of FoxP3-GFP expression, providing a convenient
marker for FoxP3. HP-BMDC were co-cultured with these T cells
and stimulated with OVA and the activated T cells were assessed
by flow cytometery for GFP (Figure 6A and6B). WT and IRAK-
M2/2 BMDCs did not differ in their ability to generate Tregs. To
determine whether IRAK-M expression influences Treginduction
in response to H. pylori in vivo, we sorted CD4+ GFP2 T cells from
Foxp3-GFP C57BL/6 animals to eliminate natural Treg cells and
any preexisting iTreg cells. These GFP negative cells were used for
adoptive transfer into WT and IRAK-M2/2 recipients. Recipient
mice were subsequently infected with H. pylori and the amount of
new FoxP3-GFP expression was determined four weeks later by
isolating gastric tissue and using qPCR analysis. H. pylori infection
in WT animals resulted in the induction of Foxp3 expression in the
gastric mucosa (Figure 7, P,0.05). Gastric tissue from IRAK-M2/
2 animals also had increased Foxp3 expression after H. pylori
infection but levels were comparable to those observed in the
gastric tissue of WT animals. Together, this data suggests that the
proinflammatory phenotype of IRAK-M2/2 BMDCs does not
affect Treg generation.
Figure 5. IRAK-M2/2 BMDCs do not increase TH17 induction in vitro. (A) BMDCs isolated from WT and IRAK-M
2/2 mice were plated and
pulsed with OVA for 2 hours before CD4+ T cells isolated from OT-II Foxp3-GFP animals were added to the wells in the presence of IL-6 and TGFb for
72 hours. Cells were restimulated with PMA and ionomycin in the presence of monesin, and production of IL-17A in CD4+ T cells was measured by
flow cytometry. (B) Data are representative of three independent experiments. Bar graph represents mean 6 SD from data collected from three
individual experiments performed in duplicate.
doi:10.1371/journal.pone.0066914.g005
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Discussion
Recent studies have demonstrated that DCs play an important
immunoregulatory role in H. pylori infection and may even impact
susceptibility or severity of other diseases such as asthma
development [11,12,27,32,47]. An understanding of the molecular
pathways that are activated in DCs by H. pylori, therefore, could
provide significant insight into how immunoregulatory and
inflammatory pathways are controlled during the course of
infection and how these mechanisms may act more broadly. In
the present study, we used a microarray approach to identify
molecules in DCs whose expression is changed most significantly
by H. pylori. We identified IRAK-M as a potential important
regulatory protein for further characterization.
By comparing HP-BMDCs to EC-BMDCs in our microarray
study, H. pylori appeared to be weakly immunogenic as only 10
gene expression changes were apparent after 24 hours. Although
this contrasted significantly with the 2162 gene expression changes
seen in the EC-BMDCs, our data are consistent with previous
microarray analyses on H. pylori-activated cells. One study
conducted a BMDC microarray following H. pylori exposure
observed 126 gene expression changes after six hours [30]. A more
recent study using H. pylori LPS stimulation of HEK293 cells
reported only three significant gene expression changes after
24 hours [48]. The low number of gene expression changes may
be a reflection of H. pylori pathogen associated molecular patterns
(PAMPs)having reduced TLR stimulating activity and that after
24 hours, the induced expression of early genes may no longer be
evident. The LPS is well documented to lack endotoxin activity,
and structural studies confirm that the length and number of its
lipid chains do not favor binding to TLR4 [49–51]. The flagellin
protein has also been shown to lack the consensus sequence
typically associated with binding to TLR5 [52].
Among the TLRs, TLR2 has been demonstrated to play a
dominant role on the activation of APC by H. pylori[31]. We
therefore investigated IRAK-M, a negative regulator of TLR
signaling, in greater detail [33]. IRAK-M lacks kinase activity and
its expression pattern was initially thought to be restricted to the
monocyte/macrophage lineage [53]. It is now known that IRAK-
M may also be expressed in dendritic cells and epithelial cells and
is a key factor in endotoxin tolerance [33,41,54,55]. IRAK-M2/2
BMDCs secrete increased levels of TH1 cytokines such as IFNc,
and skew the T cell response in vivotowards a more proin-
flammatory phenotype to prolong survival in a tumor vaccine
model [41]. In a separate study, IRAK-M2/2 BMDCs that were
tolerized to LPS exhibited higher levels of MHCII and lower levels
of IL-10 [42].
In our study, IRAK-M2/2 BMDCs stimulated with H. pylori
also displayed a more pro-inflammatory phenotype compared to
WT BMDCs. IRAK-M2/2 BMDCs displayed increased MHC II
expression and higher MIP-2, TNFa production, and also
produced less immunoregulatory IL-10 and PD-L1. IRAK-M
expression was shown to be dependent on TLR2 and TLR4
activation. Both TLR2 and TLR4 have been shown to be
important in H. pylori infection [31]. Despite the impact of the
IRAK-M deficiency on MHC II and cytokine balance in HP-
BMDCs, IRAK-M2/2 DCs failed to change the balance of T cell
subsets induced in vitro. DCs have been shown to affect the
balance of TH17 and Treg cells and to influence the outcome of H.
pylori infection [12]. IRAK-M2/2 DCs however were comparable
to WT DCs in generating TH17 and Treg in vitro. Additionally,
the IRAK-M deficiency in mice did not affect iTreg generation in
vivo.
IRAK-M appears to play different roles in other infections and
can be either beneficial or deleterious to the host [35,36,40,54,56].
For example, IRAK-M deficiency led to improved bacterial
clearance and host survival in response to both Streptococcus
pneumoniae and Klebsiella pneumoniae infections [35,36]. In contrast,
IRAK-M deficiency is deleterious to the host after influenza
infection because the pro-inflammatory phenotype leads to more
extensive lung injury in the host [40]. These studies all indicate
that IRAK-M helps limit inflammation against pathogenic
microbes, an event that can be beneficial to the host, as in the
case of influenza infection. Interestingly, gut commensals have also
been shown to activate IRAK-M expression and in the absence of
both IRAK-M and IL-10, mice were more prone to developing
colitis [34].
Of possible relation to H. pylori infection, in human genetic
studies, IRAK-M has also been associated with asthma in an
Italian cohort [57]. The association was not observed in either
Japanese or German groups [58,59]. Given the link between H.
Figure 6. IRAK-M2/2 BMDCs do not affect Treg induction in vitro. (A) BMDCs isolated from WT and IRAK-M
2/2 mice were plated and pulsed
with OVA for 2 hours before CD4+ T cells isolated from OT-II Foxp3-GFP animals were added to the wells in the presence of IL-2 and TGFb for
72 hours. Cells were restimulated with PMA and ionomycin in the presence of monesin, and Foxp3-GFP expression in CD4+ T cells was measured by
flow cytometry.Data are representative of three independent experiments. (B) Bar graph represents mean 6 SD from data collected from three
individual experiments performed in duplicate.
doi:10.1371/journal.pone.0066914.g006
Figure 7. IRAK-M deficiency does not affect iTreg generation in
vivo. GFP2CD4+ T cells were isolated from Foxp3-GFP mice and sorted
forlack of GFPexpression. 26105 GFP2 cells were transferred to the
indicated recipient mice i.v. Mice were left untreated or infected with H.
pylori SS1 for 8 weeks. RNA was isolated from gastric tissue to
determine relative GFP expression in the stomach. Each group
contained 3-6 mice. Bar graph represents mean 6 SD. N.D = not
detectable. *, P,0.05.
doi:10.1371/journal.pone.0066914.g007
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pylori infection and the reduced incidence of asthma in a variety of
studies [24,27,32], it will be interesting to further dissect how
IRAK-M affects the host response in H. pylori infection, and
whether it has consequences at other mucosal sites such as the
lung. We are currently working on further elucidating the role of
IRAK-M in H. pylori infection and looking at parameters of the
immune response outside of DCs activation.
In summary, we present data to demonstrate that H. pylori
upregulates IRAK-M expression in DCs. We also show that
IRAK-M normally functions to downregulate events associated
with immune activation such as MHCII expression and MIP-2
production, and promotes regulatory activity such as the
production of IL-10 and expression of PD-L1. IRAK-M expres-
sion as well as the activities associated with IRAK-M were
dependent upon TLR2, and to a lesser extent TLR4 activation.
However, we were unable to demonstrate that IRAK-M plays a
role in skewing the balance between TH17 and Treg cells. Thus,
the manifestation of IRAK-M expression may be in limitations in
acute or innate host responses. It will be noteworthy to explore
how IRAK-M may affect the variety of disease outcomes in H.
pylori infection and whether there may be any therapeutic potential
in modulating IRAK-M expression.
Supporting Information
Figure S1 GM-CSF BMDCs and Flt3L BMDCs share
similar cytokine profiles when IRAK-M is deficient.
Supernatant from WT and IRAK-M2/2 BMDCs generated by
the two different methods stimulated with either live H. pylori SS1
(MOI 10) or SS1 and 26695 antigen lysate were collected at 24 h
and used to determine TNFa and IL-10 levels by ELISA. Data
reflects two independent experiments. Error bars indicate standard
deviations. *, P,0.05.
(TIF)
Figure S2 WT and IRAK-M deficient BMDCs have
similar T cell differentiation capabilities in the presence
of H. pylori stimulation. BMDCs isolated from WT and
IRAK-M2/2 mice were plated and pulsed with either media or H.
pylori SS1 lysate for 2 hours before CD4+ T cells isolated from SS1
infected C56BL/6 animals were added to the wells for 72 hours.
Cells were restimulated with PMA and ionomycin in the presence
of monesin, and production of (A) IFNc, (B) IL-17A or (C) Foxp3
in CD4+ T cells was measured by flow cytometry.
(TIF)
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